23 specialty configurations vs. one general-purpose agent
A dermatology front desk and an oncology front desk field very different calls, and Assort Health has built its entire pitch around that difference: a specialty-specific voice agent for each. Fini takes the opposite bet, one agent, configured to a team's own systems, priced the same way regardless of specialty. Both approaches have real evidence behind them.
In this comparison: What each is · How they differ · Capabilities · Feature by feature · Ease of use · What customers say · The full side-by-side · Which to choose · Compliance · FAQ
What is Fini?
Fini is an AI customer-support agent priced per resolution, backed by Y Combinator and Matrix Partners. It connects natively to your helpdesk, knowledge base, CRM, billing, claims, and EHR systems, reaches a 90% resolution rate at 99% accuracy, and is built to be live in 14 days and fully autonomous in 30. Across its customer base, Fini handles more than 3 million monthly resolutions in fintech and healthcare. The agent works across voice, chat, and email, answers in 130+ languages, and returns a first response in about five seconds.
Pricing starts at $0.49 per resolution, with no per-seat fees, so a team can model its own cost from ticket volume alone, before a sales conversation ever starts.
What is Assort Health?
Assort Health is a San Francisco-based voice AI company founded in 2023 by co-CEOs Jeffery Liu and Jonathan Wang. The company has raised more than $222 million across a seed round and three priced rounds, most recently a $120 million Series C in June 2026 led by Menlo Ventures, reaching a $1.2 billion valuation roughly three years after founding. It is not Y Combinator or Matrix Partners backed.
Assort builds voice agents tuned to 23-plus medical specialties, covering the full patient-access workflow: scheduling, intake, insurance eligibility, referral and fax automation, payment resolution, and medication refills. Named customers include John Muir Health, Carbon Health, and Golden Valley Health Centers, and the company reports its agents have handled more than 190 million patient interactions.
Assort Health pricing in 2026
Assort Health does not publish pricing anywhere on its site. The only path to a quote is booking a demo; third-party estimates outside the company's own materials describe monthly fees ranging from roughly $1,500 for smaller clinics into five figures for larger groups, but these figures come from outside observers, not Assort Health itself, and should not be treated as confirmed.
Fini publishes its rate directly: $0.49 per resolution, starting rate, with no per-seat fees and no separate platform charge. An Assort Health buyer has to book a demo before learning any real number. A Fini buyer can model the exact cost of their next 1,000 resolutions from the published rate alone.
What buyers ask | Assort Health | Fini |
|---|---|---|
Published price list | ✗ | ✓ |
Price | Not published, quoted per practice after a demo | $0.49 per resolution |
Free trial or self-serve | None, demo request only | Not self-serve, staged onboarding team instead |
Vertical served | Healthcare, 23+ specialties | Fintech and healthcare |
Can you model cost before a sales call? | No | Yes |
See Fini's full pricing breakdown for plan details, add-ons, and a resolution calculator.
How Fini and Assort Health differ
Assort Health builds toward specialty depth: separate, tuned configurations across more than 23 medical specialties, from orthopedics to oncology, backed by a claimed dataset of 190 million-plus patient interactions and tens of thousands of care protocols. Fini instead runs one agent, configured to a team's own systems and knowledge base, applied consistently across fintech and healthcare rather than specialty by specialty. Assort Health publishes no pricing at all, while Fini's $0.49 per resolution is visible before a sales call.
The two companies are also at different points in scale and growth. Assort Health reached a $1.2 billion valuation roughly three years after founding, one of the fastest healthcare AI companies to reach unicorn status, backed by more than $222 million in funding. Fini competes on transparency and a published outcome guarantee rather than headline funding or valuation numbers.
Capabilities side by side
Both platforms genuinely execute tasks rather than only answering questions. Assort Health's voice agents handle 24/7 scheduling, proactive outbound outreach, insurance eligibility verification, referral and fax automation, patient payment resolution, and medication refills, tuned per specialty. Fini connects natively across helpdesk, CRM, billing, claims, and EHR systems in one connector set, and adds voice as a native channel alongside chat and email.
Assort Health reports a 97% resolution rate and cites customer-level results like an 8% call abandonment rate, down from 41%, achieved within 30 days. Fini publishes its own outcome metrics directly: a 90% resolution rate at 99% accuracy, covered further in the Compliance section below.
Feature by feature
Feature | Fini | Assort Health |
|---|---|---|
Channels | Voice, chat, email | Voice, two-way texting, online scheduling, chatbot |
Specialty-tuned configurations | Not a published product line | ✓ (23+ specialties) |
Fintech workflows (billing, claims) | ✓, native | ✗, healthcare-only focus |
Published outcome guarantee | ✓ (90-Day Money-Back Guarantee) | None published |
Published pricing | ✓ | ✗ |
Ease of use and admin experience
Assort Health's own blog states typical go-live runs 30 to 45 days, covering workflow customization, EHR integration, and a monitored launch handled by its own implementation engineers, with some customers seeing value in as few as three weeks. Fini's published staged rollout (live in 14 days, fully autonomous in 30) is run by a dedicated onboarding team against a fixed timeline that applies to every customer.
Assort Health shows 0 verified reviews on G2 as of this research, with the platform noted as having too few reviews to provide reliable buying insight, and no Capterra listing was found. Its only public satisfaction figure is a self-reported 4.3 out of 5 rating across 344,000 patient interactions, published on its own site rather than an independent review platform.
Fini's differentiators
Published, forecastable pricing
a starting rate of $0.49 per resolution, visible before any sales call, versus Assort Health's demo-gated, unpublished rate.
Fintech and healthcare, not healthcare alone
Native connections into billing and claims systems cover a second regulated vertical Assort Health does not serve.
A fixed, staged rollout: live in 14 days, fully autonomous in 30
A specific, published timeline applied to every customer, not just the fastest case studies.
A published outcome guarantee
The 90-Day Money-Back Guarantee ties payment to a 90% resolution rate within 90 days, at a publicly quoted rate.
Assort Health's recognized strengths
Assort Health earns real credit on specific, well-sourced points. Reaching a $1.2 billion valuation roughly three years after founding is a genuinely rare growth trajectory in healthcare AI, backed by more than $222 million from investors including Menlo Ventures and Lightspeed Venture Partners, alongside healthcare-industry angel investors from Athenahealth, Flatiron Health, and PathAI. Its specialty-specific approach, tuning agents separately for orthopedics, dermatology, oncology, and 20-plus other specialties, reflects a genuinely deep investment in the nuance of each specialty's call patterns rather than a one-size-fits-all script. Its named customer list, John Muir Health, Carbon Health, and Golden Valley Health Centers among others, spans a real range of health systems and multi-site practice groups.
What customers say
Assort Health shows 0 verified reviews on G2 as of this research, and no Capterra listing was found, so independent, crowd-sourced feedback was not available. Its own published case studies report a call abandonment rate reduced from 41% to 8% within 30 days at one customer, and separately cite a 97% resolution rate and a 79% referral-scheduling rate without staff intervention across its customer base. These are Assort Health's own reported figures rather than third-party-audited ones, and should be read as company claims.
The full side-by-side
Fini | Assort Health | |
|---|---|---|
Pricing | $0.49 per resolution, starting rate | Not published |
Outcome guarantee | 90-Day Money-Back Guarantee, 90% in 90 days | None published |
Go-live | Live in 14 days, fully autonomous in 30, every customer | 30 to 45 days, per Assort's own published timeline |
Channels | Voice, chat, email | Voice, texting, online scheduling, chatbot |
Vertical scope | Fintech and healthcare | Healthcare, 23+ specialties |
Compliance | SOC 2 Type II, ISO 27001, GDPR, HIPAA-BAA-eligible, CCPA under agreement | SOC 2 Type II and HIPAA/BAA stated, no ISO 27001, HITRUST, or GDPR found published |
Backing | Y Combinator, Matrix Partners | $222M+ raised, $1.2B valuation (Menlo Ventures, Lightspeed) |
Named customers | 3M+ monthly resolutions across fintech and healthcare | John Muir Health, Carbon Health, Golden Valley Health Centers |
Which should you choose?
Choose Fini if you want a published, flat per-resolution rate you can model before a sales call, a fixed rollout (live in 14 days, fully autonomous in 30), and coverage across both fintech and healthcare workflows including claims and EHR systems. Choose Assort Health if you run a specialty medical practice or health system that wants an agent tuned specifically to that specialty's call patterns and are comfortable with a demo-gated pricing process.
A useful gut check: if your team needs fintech workflows alongside healthcare ones, or wants to see the exact per-resolution rate before a scoped sales conversation, Fini's published pricing and rollout (live in 14 days, fully autonomous in 30) are built for exactly that situation. If you specifically run a specialty practice, orthopedics, oncology, dermatology, and want an agent built around that specialty's specific call patterns, Assort Health's depth is the more relevant comparison. See how Fini also compares against Syllable and Hyro, two other healthcare-focused platforms in this category.
Compliance
Fini publishes SOC 2 Type II, ISO 27001, GDPR compliance, HIPAA-compliant BAA-eligible contracting, and CCPA availability under agreement, all listed together in one place. Assort Health states on its own site that it is HIPAA compliant, signs a Business Associate Agreement with every customer, and holds SOC 2 Type II certification, alongside encryption, multi-factor authentication, and role-based access controls. No mention of HITRUST certification, ISO 27001 certification, or GDPR compliance was found for Assort Health in any source reviewed.
That gap matters differently depending on the buyer. A US-only healthcare practice with no international patients may find Assort Health's SOC 2 and HIPAA posture sufficiently thorough for its needs. A team that also touches fintech workflows or European patient data has no equivalent claim to evaluate from Assort Health at all, since the product does not appear to serve those cases.
Ready to compare on your own data?
The fastest way to know which platform actually fits your ticket volume and compliance requirements is to run the numbers against your own data rather than a vendor's published averages. See Fini's plans or talk to the team about a side-by-side pilot. If you're also weighing another healthcare-focused platform, our Syllable vs Fini comparison covers a platform that, unusually for this category, does publish metered pricing, and our explainer on KYC automation covers how onboarding-checks workflows work across this category.
Is Assort Health's pricing public?
No. Assort Health does not publish pricing anywhere on its site, and a specific quote requires booking a demo. Fini publishes its rate directly: $0.49 per resolution, starting rate.
Who founded Assort Health and when?
Assort Health was founded in 2023 by co-CEOs Jeffery Liu and Jonathan Wang. The company is headquartered in San Francisco, California.
How much has Assort Health raised?
Assort Health has raised more than $222 million across a seed round and three priced rounds, most recently a $120 million Series C in June 2026 led by Menlo Ventures, reaching a $1.2 billion valuation. It is not Y Combinator or Matrix Partners backed.
Does Assort Health serve fintech companies?
No. Assort Health is built exclusively for healthcare provider organizations across more than 23 medical specialties. Fini serves both fintech and healthcare, with native connections into billing and claims systems.
How fast can each platform go live?
Fini publishes a staged rollout for every customer: live in 14 days, fully autonomous in 30. Assort Health's own blog states typical go-live runs 30 to 45 days, with some customers seeing value in as few as three weeks.
What specialties does Assort Health support?
Assort Health markets specialty-tuned voice agents across more than 23 medical specialties, including orthopedics, dermatology, ophthalmology, women's health, pediatrics, cardiology, and oncology, per its own site.
Is Assort Health SOC 2 and HIPAA compliant?
Assort Health states on its own site that it is HIPAA compliant, signs a Business Associate Agreement with every customer, and holds SOC 2 Type II certification. No HITRUST, ISO 27001, or GDPR claim was found published. Fini publishes SOC 2 Type II, ISO 27001, GDPR, HIPAA-BAA-eligible contracting, and CCPA together.
Does Fini offer any guarantee Assort Health doesn't?
Fini's 90-Day Money-Back Guarantee ties payment to results, a 90% resolution rate within 90 days, at a publicly quoted rate. No equivalent outcome guarantee was found published on Assort Health's site.
Who are Assort Health's named customers?
John Muir Health, Carbon Health, Golden Valley Health Centers, Women's Health Arizona, and U.S. Urology Partners are among the customers named on Assort Health's own site.
Does Assort Health have independent reviews on G2 or Capterra?
Assort Health shows 0 verified reviews on G2 as of this research, with too few reviews to provide reliable buying insight, and no Capterra listing was found. Its only public satisfaction figure is a self-reported 4.3 out of 5 rating on its own site.
